Jornay PM Trial
Phase 4
30
about 1 year
18–60
1 site in NY
About this study
This trial is testing a treatment called Jornay PM (methylphenidate hydrochloride extended-release capsules) for adult ADHD symptoms. The goal is to see how long this treatment works and if it helps with daytime symptoms, executive function, and emotional regulation.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Methylphenidate Hydrochloride Extended Release Capsule
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
methylphenidate (CNS stimulant; blocks reuptake of dopamine and norepinephrine)
oral (Oral Tablet)
Primary: Change in Expanded Adult ADHD Investigator Symptom Rating Scale (AISRS) Score from Baseline to Week 10, Change in Expanded Adult ADHD Investigator Symptom Rating Scale (AISRS) Score from Baseline to Week 3
Secondary: 11-Hours Post-Dose Time-Sensitive ADHD Symptom Scale (TASS) Score at Visit 3, Change from Baseline in Clinical Global Impression-Severity (CGI-S) Scale Score, Change in Adult ADHD Self Report Scale (ASRS) Symptom Checklist Score
Psychiatry / Mental Health